All Industry News articles
-
NewsLancaster University spinout secures funding to advance healthcare diagnostics
Lancaster University spin out CCI Photonics has secured significant funding to develop its diagnostic technology, which aims to improve healthcare outcomes by using AI to detect infectious diseases and determine patients’ antibiotic susceptibilities in under 15 minutes.
-
NewsRising threat of carbapenem-resistant Enterobacteriales (CRE) spurs urgent healthcare alert
The deteriorating epidemiological situation of carbapenem-resistant Enterobacteriales (CRE) has spurred ECDC to alert EU/EAA countries to the importance of controlling the spread of CRE infections to safeguard their healthcare systems.
-
NewsGlobal research on hydrothermal pretreatment: A green leap for biorefineries
From a global analysis of the research in hydrothermal pretreatment, a bibliometric study highlights its use as the future of biorefineries for sustainable biomass conversion.
-
NewsValneva reports high sustained immune response in adolescents one year after Chikungunya Vaccine
Valneva SE, a specialty vaccine company, has reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, which showed a sustained 98.3% sero-response rate one-year after single vaccination.
-
NewsCARB-X funds Melio to develop rapid diagnostic to detect neonatal sepsis
CARB-X will award biotechnology company Melio US$3.5M to develop and execute a technical feasibility workplan for its culture-free platform designed to identify blood stream infections including neonatal sepsis.
-
NewsCARB-X funds Peptilogics to develop a novel, broad-spectrum therapeutic to treat fracture-related infections
CARB-X will award Peptilogics US$3.3 million to develop and execute a workplan for its slow-release formulation of a novel, broad-spectrum therapeutic, zaloganan-CR, an engineered peptide intended for use in preventing infection after high-energy-traumatic bone injuries.
-
NewsStart-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
-
NewsBreakthrough infection test designed to tackle AMR on target for 2025 UK NHS availability after positive trial results
UK medtech company Presymptom Health has announced positive results from its clinical trial of diagnostic technology in the management of infection and sepsis in patients presenting to Emergency Departments with respiratory infection.
-
NewsNew collaboration aims to optimize nutrient uptake and tolerance to environmental stress with crop boosting fungi
A joint program to develop methods to accelerate and optimize the in vitro growth of AMF (arbuscular mycorrhizal fungi) for more sustainable agriculture has been announced.
-
NewsNew mechanism to fund clinical studies addressing the impact of diet, nutrition, and microbiome on lupus
The unique IDEAL (Investigate Dietary Approaches for Lupus) Initiative will provide multi-disciplinary research teams the opportunity to conduct innovative and much-needed research of diet in lupus.
-
NewsWomen’s health company Freya Biosciences announces key $10.4m strategic investment
Freya Biosciences, a transatlantic biotech company specializing in women’s health, has announced a major strategic investment which will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis.
-
NewsSLEEVER® and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal
SLEEVER®, and CARBIOS have unveiled the first innovation to emerge from their partnership: SEELCAP® ONEGO, the world’s first Home Compost biodegradable tamper evident seal which integrates the encapsulated enzyme CARBIOS Active.
-
NewsBiofuel breakthrough: Rhodococcus strain N1-S transforms succinic acid production
A new study reveals that Rhodococcus aetherivorans strain N1-S boosts succinic acid yields by 6.5 times, promising a more efficient path to sustainable biofuels.
-
NewsFecal DNA testing could reduce global colonoscopy burden: experts
Experts gathered at the ICG 19 · Metagenomics for Health (ICG19·MH) & The 2nd MOHA Consortium have highlighted the global challenge of limited access to colonoscopy, the gold standard for CRC screening.
-
NewsFleming Initiative raises first £100m in the global fight against AMR
Three new partners have pledged additional funding and resources to the Fleming Initiative’s global effort to combat antimicrobial resistance (AMR), as leading medical expert Professor Lord Ara Darzi calls for tighter restrictions on the use of antibiotics.
-
NewsRwanda and BGI Genomics forge stronger ties in public health collaboration
Dr. Sabin Nsanzimana, the Minister of Health of Rwanda, along with Samuel Abikunda, Commercial Counsellor from the Embassy of Rwanda in China, led a high-level delegation to BGI Genomics on September 8, 2024.
-
NewsKorea University Vaccine Innovation Center teams with Moderna on mRNA-based hantavirus vaccine development
The Vaccine Innovation Center at Korea University College of Medicine has entered into a full-scale collaboration with global pharmaceutical company Moderna to develop an mRNA-based hantavirus vaccine.
-
NewsValneva and LimmaTech team up to accelerate tetravalent Shigella vaccine candidate
Valneva SE and LimmaTech Biologics AG have entered into a strategic partnership and exclusive licensing agreement for the development, manufacturing and commercialization of Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis.
-
NewsResearchers collaborate for early monitoring of tar spot disease in corn
Insignum AgTech has begun a collaboration with researchers in Purdue University’s College of Agriculture and College of Engineering to create tools for farmers to identify early stages of tar spot disease outbreaks in their corn plants.
-
NewsFedEx opens first European Life Science Center in Veldhoven
Federal Express Corporation, the world’s largest express transportation company, has opened its first European Life Science Center in Veldhoven, the Netherlands. The specialised cooling facility opens global access for the healthcare industry.
